Background: In vivo evidence for angiogenesis in the splanchnic vasodilation in portal hypertension (PHT) and cirrhosis is lacking. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) are mediators of angiogenesis. The present study visualises in vivo structural changes (angiogenesis and vascular hyperpermeability) and examines the presence of VEGF and eNOS in the mesenteric microvasculature of animal models of PHT with and without cirrhosis. Methods: Portal hypertension was induced by partial portal vein ligation (PPVL) and cirrhosis was induced by common bile duct ligation (CBDL) in rats. The mesenteric microcirculation was examined by intravital microscopy. Expression of VEGF, eNOS and CD31 in mesenteri...
Portal hypertension (PH) is a common complication and a leading cause of death in patients with chro...
Portal hypertension (PHT) is the most common cause of cirrhosis. Since portal pressure is dependent ...
We tested the potential role of vascular endothelial growth factor (VEGF) and of fibroblast growth f...
Background: In vivo evidence for angiogenesis in the splanchnic vasodilation in portal hypertension ...
In vivo evidence for angiogenesis in the splanchnic vasodilation in portal hypertension (PHT) and ci...
Background and aims: The extent and molecular mechanisms governing plasma extravasation and formatio...
To determine the pathogenesis of liver nodules, and lesions similar to obliterative portal venopathy...
Background: In liver cirrhosis, a marked splanchnic vasodilation causes an increase in portal blood ...
This intravital fluorescence microscopy (IVFM) study validates cirrhotic mice models and describes t...
In patients with advanced liver disease with portal hypertension, portal-systemic collaterals contri...
BACKGROUND & AIMS: Portal hypertension is responsible for the major complications associated with ci...
BACKGROUND: Cirrhotic portal hypertension is characterized by mesenteric arterial vasodilation and h...
Portal hypertension (PH) is a common complication and a leading cause of death in patients with chro...
BACKGROUND: Cirrhotic portal hypertension is characterized by mesenteric arterial vasodilation and h...
Copyright © 2015 Bin Wen et al.This is an open access article distributed under the Creative Commons...
Portal hypertension (PH) is a common complication and a leading cause of death in patients with chro...
Portal hypertension (PHT) is the most common cause of cirrhosis. Since portal pressure is dependent ...
We tested the potential role of vascular endothelial growth factor (VEGF) and of fibroblast growth f...
Background: In vivo evidence for angiogenesis in the splanchnic vasodilation in portal hypertension ...
In vivo evidence for angiogenesis in the splanchnic vasodilation in portal hypertension (PHT) and ci...
Background and aims: The extent and molecular mechanisms governing plasma extravasation and formatio...
To determine the pathogenesis of liver nodules, and lesions similar to obliterative portal venopathy...
Background: In liver cirrhosis, a marked splanchnic vasodilation causes an increase in portal blood ...
This intravital fluorescence microscopy (IVFM) study validates cirrhotic mice models and describes t...
In patients with advanced liver disease with portal hypertension, portal-systemic collaterals contri...
BACKGROUND & AIMS: Portal hypertension is responsible for the major complications associated with ci...
BACKGROUND: Cirrhotic portal hypertension is characterized by mesenteric arterial vasodilation and h...
Portal hypertension (PH) is a common complication and a leading cause of death in patients with chro...
BACKGROUND: Cirrhotic portal hypertension is characterized by mesenteric arterial vasodilation and h...
Copyright © 2015 Bin Wen et al.This is an open access article distributed under the Creative Commons...
Portal hypertension (PH) is a common complication and a leading cause of death in patients with chro...
Portal hypertension (PHT) is the most common cause of cirrhosis. Since portal pressure is dependent ...
We tested the potential role of vascular endothelial growth factor (VEGF) and of fibroblast growth f...